Close Menu

There's a silver lining to this downturn, and John Browning touches on it in an essay in this week's issue of Nature. "Venture funding is declining quickly and is unlikely to bounce back," he writes. "But less money means lower expectations – good news for smaller science start-ups." While the 1990s boom meant expectations that many companies couldn't meet, today's market gives smaller, less ambitious projects a better chance.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.